Aurinia Pharmaceuticals Inc. (AUPH) vs Fortrea Holdings Inc. (FTRE)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Fortrea Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs FTRE

growth of $100 · dividends reinvested · last 3y
AUPH +58.3% (+16.5%/yr)FTRE -34.0% (-12.9%/yr)AUPH compounded faster over this window
050100150Start $100202420252026$158$66
AUPH FTRE

AUPH vs FTRE: by the numbers

  • •FTRE is the larger company ($2.07B vs $2.03B market cap).
  • •AUPH is profitable (100.84% net margin) while FTRE runs a net loss (-3.18%).
  • •AUPH grew revenue faster over the past five years (40.17% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricAUPHFTRE
P/E ratio6.89N/A
Forward P/E16.7225.92
P/S ratio6.510.77
P/B ratio3.303.95
EV / EBITDA11.2333.84
FCF yield8.55%7.26%

Profitability

MetricAUPHFTRE
Gross margin90.36%17.11%
Operating margin37.06%0.41%
Net margin100.84%-3.18%
ROE51.09%-16.25%
ROIC21.77%0.62%

Growth (annualized)

MetricAUPHFTRE
Revenue CAGR (5Y)40.17%1.09%
FCF CAGR (5Y)N/A-12.98%
Total return CAGR (5Y)-5.88%N/A

Frequently asked

Which has grown faster, AUPH or FTRE?
Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus FTRE at 1.09%.
Is AUPH or FTRE more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus FTRE at -3.18%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.